Načítá se...

EGFRvIII-specific CAR-T cells produced by piggyBac transposon exhibit efficient growth suppression against hepatocellular carcinoma

Adoptive cellular immunotherapy employing chimeric antigen receptors-modified T (CAR-T) cells has demonstrated promising antitumor effects in hematologic cancers. However, CAR-T therapy confront many challenges in solid tumors like immunosuppressive microenvironment, molecular heterogeneity, etc. Th...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Med Sci
Hlavní autoři: Ma, Yuan, Chen, Yan, Yan, Lei, Cao, Hui-Xia, Han, Shuang-Yin, Cui, Jun-Jun, Wen, Jian Guo, Zheng, Yan
Médium: Artigo
Jazyk:Inglês
Vydáno: Ivyspring International Publisher 2020
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7330669/
https://ncbi.nlm.nih.gov/pubmed/32624697
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijms.45603
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!